These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29901990)

  • 1. Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy.
    Cairns AG; Vazquez-Romero A; Mahdi Moein M; Ådén J; Elmore CS; Takano A; Arakawa R; Varrone A; Almqvist F; Schou M
    ACS Chem Neurosci; 2018 Nov; 9(11):2542-2547. PubMed ID: 29901990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Multiring Fused 2-Pyridones via a Nitrene Insertion Reaction: Fluorescent Modulators of α-Synuclein Amyloid Formation.
    Singh P; Chorell E; Krishnan KS; Kindahl T; Åden J; Wittung-Stafshede P; Almqvist F
    Org Lett; 2015 Dec; 17(24):6194-7. PubMed ID: 26650849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of α-synuclein fibrillization by ring-fused 2-pyridones: templation and inhibition involve oligomers with different structure.
    Horvath I; Sellstedt M; Weise C; Nordvall LM; Krishna Prasad G; Olofsson A; Larsson G; Almqvist F; Wittung-Stafshede P
    Arch Biochem Biophys; 2013 Apr; 532(2):84-90. PubMed ID: 23399432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P
    Pekošak A; Bulc JŽ; Korat Š; Schuit RC; Kooijman E; Vos R; Rongen M; Verlaan M; Takkenkamp K; Beaino W; Poot AJ; Windhorst AD
    Mol Pharm; 2018 Nov; 15(11):4872-4883. PubMed ID: 30335399
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Maurer A; Leonov A; Ryazanov S; Herfert K; Kuebler L; Buss S; Schmidt F; Weckbecker D; Linder R; Bender D; Giese A; Pichler BJ; Griesinger C
    ChemMedChem; 2020 Mar; 15(5):411-415. PubMed ID: 31859430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ¹¹C-labeled analogs of indomethacin esters and amides for brain cyclooxygenase-2 imaging: radiosynthesis, in vitro evaluation and in vivo characteristics in mice.
    Yamamoto Y; Toyohara J; Ishiwata K; Sano K; Yamamoto F; Mukai T; Maeda M
    Chem Pharm Bull (Tokyo); 2011; 59(8):938-46. PubMed ID: 21804236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sobetirome prodrug esters with enhanced blood-brain barrier permeability.
    Placzek AT; Ferrara SJ; Hartley MD; Sanford-Crane HS; Meinig JM; Scanlan TS
    Bioorg Med Chem; 2016 Nov; 24(22):5842-5854. PubMed ID: 27707627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esterification of PQQ Enhances Blood-Brain Barrier Permeability and Inhibitory Activity against Amyloidogenic Protein Fibril Formation.
    Tsukakoshi K; Yoshida W; Kobayashi M; Kobayashi N; Kim J; Kaku T; Iguchi T; Nagasawa K; Asano R; Ikebukuro K; Sode K
    ACS Chem Neurosci; 2018 Dec; 9(12):2898-2903. PubMed ID: 30074759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy.
    Kikuchi A; Takeda A; Okamura N; Tashiro M; Hasegawa T; Furumoto S; Kobayashi M; Sugeno N; Baba T; Miki Y; Mori F; Wakabayashi K; Funaki Y; Iwata R; Takahashi S; Fukuda H; Arai H; Kudo Y; Yanai K; Itoyama Y
    Brain; 2010 Jun; 133(Pt 6):1772-8. PubMed ID: 20430832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
    Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
    Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
    Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
    Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[(11)C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase.
    Shimoda Y; Fujinaga M; Hatori A; Yui J; Zhang Y; Nengaki N; Kurihara Y; Yamasaki T; Xie L; Kumata K; Ishii H; Zhang MR
    Bioorg Med Chem; 2016 Feb; 24(4):627-34. PubMed ID: 26740152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging.
    Verdurand M; Levigoureux E; Zeinyeh W; Berthier L; Mendjel-Herda M; Cadarossanesaib F; Bouillot C; Iecker T; Terreux R; Lancelot S; Chauveau F; Billard T; Zimmer L
    Mol Pharm; 2018 Aug; 15(8):3153-3166. PubMed ID: 29989823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of P-glycoprotein function at the blood-brain barrier in nonhuman primates using [11C]verapamil.
    Lee YJ; Maeda J; Kusuhara H; Okauchi T; Inaji M; Nagai Y; Obayashi S; Nakao R; Suzuki K; Sugiyama Y; Suhara T
    J Pharmacol Exp Ther; 2006 Feb; 316(2):647-53. PubMed ID: 16293715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
    Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
    Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the PET radiotracer [¹⁸F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice.
    Levigoureux E; Lancelot S; Bouillot C; Chauveau F; Verdurand M; Verchere J; Billard T; Baron T; Zimmer L
    Curr Alzheimer Res; 2014; 11(10):955-60. PubMed ID: 25387331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates.
    Schou M; Varnäs K; Lundquist S; Nakao R; Amini N; Takano A; Finnema SJ; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2015 Mar; 18(10):pyv036. PubMed ID: 25813017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo quantification of glial activation in minipigs overexpressing human α-synuclein.
    Lillethorup TP; Glud AN; Landeck N; Alstrup AKO; Jakobsen S; Vang K; Doudet DJ; Brooks DJ; Kirik D; Hinz R; Sørensen JC; Landau AM
    Synapse; 2018 Dec; 72(12):e22060. PubMed ID: 30009467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-Beta Radiotracer [
    Verdurand M; Levigoureux E; Lancelot S; Zeinyeh W; Billard T; Quadrio I; Perret-Liaudet A; Zimmer L; Chauveau F
    Contrast Media Mol Imaging; 2018; 2018():9165458. PubMed ID: 29551958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.